IndraLab
Statements
reach
"Mechanistically, EVO directly interacts with USP4, thereby disrupting the protein stability of SOX9.In this study, we demonstrated that evodiamine inhibits colorectal cancer (CRC) stemness by disrupting USP4-mediated SOX9 stabilization, providing novel insights into the molecular mechanisms of CRC progression."